University of Virginia Health System

EDUCATION:

Medical School: University of Dundee, Scotland – MBChB (MD equivalent)

Graduate School: University of North Carolina at Chapel Hill -  MA, Public Health (Health Policy and Administration), 1993

Internships: Kingscross Hospital, Dundee, Scotland – Infectious Disease and Respiratory Medicine intern (6 mos. 1984)
Royal Cornwall Hospital, Truro, England – General Surgery intern (6 mos. 1985)

Residency: University of Virginia, School of Medicine, Charlottesville, VA. 1997 - 2001

Fellowships: University of Virginia, School of Medicine, Charlottesville, VA. Fellow in Cytopathology 2001 – 2002
Duke University, Durham , NC – Fellow in Anatomic Pathology 1985-1986
Armed Forces Institute of Pathology – Fellow in Cytopathology October 1999

CLINICAL:
Surgical pathology and renal pathology.

RESEARCH:

• Investigation of protein expression profiles of primarily gynecologic tumors by immunohistochemical methods and with the use of tissue microarrays. Application of these methods to guide inclusion of patients in trials evaluating the immunogenicity of cancer-associated peptides. Particular tumors being studied include high-grade ovarian and endometrial carcinomas.
• Assessing the influence on rate and types renal allograft rejection using a new immunosuppressive regimen. Investigating whether markers identified in the course of microarray profiling of renal allograft biopsies, indeed prove useful as predictors of poor allograft survival.

REFERENCES:

• Stelow EB, Woon C, Atkins  KA, Bardales RH, Cathro HP, Frierson HF Jr, Stanley MW, Savik K, and Pambuccian SE.  Interobserver variability with the interpretation of thyroid FNA specimens showing predominantly Hürthle cells.  Am J Clin Pathol 2006; 126(4): 580-583.
• Lommatzsch SE, Bellizzi AM, Cathro HP, and Rosner MH.  Acute renal failure caused by renal infiltration by hematolymphoid malignancy. Annals of Diagnostic Pathology 2006; 10: 230-234.
• Cathro, HP and Stoler MH.  The utility of calretinin, inhibin and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.  Human Pathology 2005; 36(2): 195-201.
• Hu D, Cathro HP and Okusa MD.  Polymorphonuclear leukocyte infiltration in acute interstitial nephritis of Sjögren's syndrome.  American Journal of Medical Science 2004; 327(5): 278-280.
• Cathro HP, Mills SE.  Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.  American Journal of Surgical Pathology 2004; 28(8):1026-32.
• Hu D, Cathro HP, Okusa MD.  Polymorphonuclear leukocyte infiltration in acute interstitial nephritis of Sjögren's syndrome.  American Journal of Medical Science 2004; 327(5):278-80.
• Frierson, H.F. Jr., Moskaluk C.A., Powell S.M., Zhang H., Cerilli L.A., Stoler M.H., Cathro H.P. and Hampton G.M. (2003) Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Human Pathology 34(6): 605-609.
• Cathro, H.P. and Stoler, M.H. (2002) Expression of cytokeratins 7 and 20 in ovarian neoplasia.  American Journal of Clinical Pathology 117:944-951.

BOOK CHAPTERS:

• Cathro HP, Stoler MH (Hayat, M.A. ed) The role of cytokeratin immunohistochemistry in the differential diagnosis of ovarian tumors. In press: Immunohistochemistry and in situ hybridization of human carcinomas.  Elsevier Science/Academic Press.

A current list of Dr. Cathro's journal publications can be obtained from PubMed.